| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $500K | — |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $5.4M | -56.9% |
| Operating Income | -$12.2M | +18.4% |
| Pre-tax Income | -$9.7M | +42.7% |
| Income Tax | $8K | — |
| Net Income | -$9.7M | +42.6% |
| EPS (Basic) | -$4.75 | -125.1% |
| EPS (Diluted) | -$4.75 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $13.7M | +575.5% |
| Total Assets | $15.1M | +30.0% |
| Current Liabilities | $3.1M | +22.4% |
| Total Liabilities | $8.3M | -3.1% |
| Stockholders' Equity | $6.8M | +123.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.9M | +71.9% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $13.4M | +264.8% |
| -125.1% |